Shanghai, China

Shengchao Lin

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: Duality Biologics (Suzhou) Co., Ltd.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shengchao Lin. Retrieved from https://idiyas.com/inventor/shengchao-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations of Shengchao Lin in Anti-Tumor Compounds

Introduction

Shengchao Lin is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-tumor compounds. With a total of six patents to his name, Lin's work is paving the way for advancements in cancer treatment.

Latest Patents

Among his latest patents is an innovative anti-tumor compound and its preparation method. This application details a compound or its various forms, including tautomers, mesomers, racemates, enantiomers, diastereoisomers, or mixtures thereof, as well as pharmaceutically acceptable salts. The preparation method and its uses are also thoroughly described, showcasing the potential impact of his work on cancer therapies.

Career Highlights

Shengchao Lin is currently associated with Duality Biologics (Suzhou) Co., Ltd. His role in this company allows him to further his research and development efforts in the pharmaceutical industry. His expertise and innovative approach have positioned him as a key figure in the fight against cancer.

Collaborations

Lin collaborates with notable colleagues, including Yu Zhang and Zhongyuan Zhu. Their combined efforts contribute to the advancement of research in anti-tumor compounds and enhance the potential for successful treatments.

Conclusion

Shengchao Lin's work in developing anti-tumor compounds represents a significant step forward in cancer research. His innovative patents and collaborations highlight his commitment to improving therapeutic options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…